Anja Duursma
Papers
1
Total Citations
32
H-Index
1
About
Anja Duursma is a cancer researcher whose work focuses on DNA damage repair and the development of targeted radiosensitizers for cancer therapy. Her key research areas include ATM kinase inhibition, cancer cell biology, and the intersection of radiation oncology with molecular pharmacology. Duursma’s most significant contribution is the identification of a novel ATM inhibitor that selectively enhances radiosensitization in cancer cells, a breakthrough published in 2017 with 32 citations. This work, conducted in collaboration with leading institutions, demonstrated a promising strategy to improve radiotherapy outcomes by specifically targeting tumor cells while sparing healthy tissue—a critical challenge in oncology. The study’s impact lies in its potential to reduce side effects and increase treatment efficacy, marking Duursma as a rising figure in translational cancer research. Her achievement reflects a deep understanding of cellular signaling pathways and drug development, offering new avenues for head and neck cancer treatment. Duursma’s research continues to influence the field, bridging basic science and clinical application to address unmet needs in cancer care.
Research Focus
Key Achievements
Top Papers
- 1